<bill session="115" type="h" number="7369" updated="2023-01-11T13:40:45Z">
  <state datetime="2018-12-20">REFERRED</state>
  <status>
    <introduced datetime="2018-12-20"/>
  </status>
  <introduced datetime="2018-12-20"/>
  <titles>
    <title type="display">DEA Notification Act of 2018</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to provide the Attorney General certain notifications in certain determinations made by the Secretary of improper prescribing of controlled substances, and for other purposes.</title>
    <title type="short" as="introduced">DEA Notification Act of 2018</title>
  </titles>
  <sponsor bioguide_id="B001257"/>
  <cosponsors>
    <cosponsor bioguide_id="R000599" joined="2018-12-20"/>
  </cosponsors>
  <actions>
    <action datetime="2018-12-20">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-12-20" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-12-20">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-12-20">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSJU" name="House Judiciary" subcommittee="" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Health care quality"/>
    <term name="Health facilities and institutions"/>
    <term name="Licensing and registrations"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-01-04T16:27:33Z" status="Introduced in House">DEA Notification Act of 2018

This bill requires the Centers for Medicare &amp; Medicaid Services to notify the Drug Enforcement Administration (DEA) of providers or suppliers that are prohibited from participating in Medicare due to improper prescriptions of controlled substances, and to recommend that the DEA consider revoking certain controlled substance registrations or waivers held by such providers or suppliers.</summary>
</bill>
